Humana Inc. (0J6Z.L)
USD 266.03
(-6.17%)
USD 266.03
(-6.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.01 Billion USD | -6.08% |
| 2022 | 4.27 Billion USD | 35.74% |
| 2021 | 3.14 Billion USD | -36.86% |
| 2020 | 4.98 Billion USD | 56.2% |
| 2019 | 3.19 Billion USD | 2.57% |
| 2018 | 3.11 Billion USD | -10.42% |
| 2017 | 3.47 Billion USD | 88.29% |
| 2016 | 1.84 Billion USD | -22.15% |
| 2015 | 2.37 Billion USD | 0.34% |
| 2014 | 2.36 Billion USD | 14.6% |
| 2013 | 2.06 Billion USD | 14.12% |
| 2012 | 1.8 Billion USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 728 Million USD | -36.2% |
| 2024 Q1 | 1.26 Billion USD | 2158.93% |
| 2024 Q2 | 1.14 Billion USD | -9.8% |
| 2023 Q2 | 1.43 Billion USD | -16.46% |
| 2023 Q1 | 1.71 Billion USD | 450.96% |
| 2023 FY | 4.57 Billion USD | 7.04% |
| 2023 Q3 | 1.27 Billion USD | -11.35% |
| 2023 Q4 | 56 Million USD | -95.6% |
| 2022 Q4 | 312 Million USD | -75.12% |
| 2022 Q2 | 1.41 Billion USD | 10.01% |
| 2022 Q1 | 1.28 Billion USD | 2013.11% |
| 2022 FY | 4.27 Billion USD | 35.74% |
| 2022 Q3 | 1.25 Billion USD | -11.57% |
| 2021 Q2 | 1.23 Billion USD | 1.06% |
| 2021 Q4 | 61 Million USD | -96.53% |
| 2021 FY | 3.14 Billion USD | -36.86% |
| 2021 Q1 | 1.22 Billion USD | 453.47% |
| 2021 Q3 | 1.75 Billion USD | 42.15% |
| 2020 Q1 | 1.07 Billion USD | 162.59% |
| 2020 Q3 | 1.82 Billion USD | -25.13% |
| 2020 Q4 | -346 Million USD | -118.98% |
| 2020 FY | 4.98 Billion USD | 56.2% |
| 2020 Q2 | 2.43 Billion USD | 126.72% |
| 2019 FY | 3.19 Billion USD | 2.57% |
| 2019 Q4 | 409 Million USD | -52.88% |
| 2019 Q3 | 868 Million USD | -22.15% |
| 2019 Q2 | 1.11 Billion USD | 31.64% |
| 2019 Q1 | 847 Million USD | 63.83% |
| 2018 Q4 | 517 Million USD | -46.2% |
| 2018 Q2 | 862 Million USD | 11.66% |
| 2018 FY | 3.11 Billion USD | -10.42% |
| 2018 Q1 | 772 Million USD | 6.48% |
| 2018 Q3 | 961 Million USD | 11.48% |
| 2017 FY | 3.47 Billion USD | 88.29% |
| 2017 Q3 | 858 Million USD | -22.0% |
| 2017 Q1 | 791 Million USD | 290.6% |
| 2017 Q4 | 725 Million USD | -15.5% |
| 2017 Q2 | 1.1 Billion USD | 39.06% |
| 2016 Q3 | 969 Million USD | 36.48% |
| 2016 FY | 1.84 Billion USD | -22.15% |
| 2016 Q4 | -415 Million USD | -142.83% |
| 2016 Q2 | 710 Million USD | 22.2% |
| 2016 Q1 | 581 Million USD | 93.02% |
| 2015 Q1 | 790 Million USD | 112.94% |
| 2015 FY | 2.37 Billion USD | 0.34% |
| 2015 Q4 | 301 Million USD | -57.37% |
| 2015 Q3 | 706 Million USD | 23.21% |
| 2015 Q2 | 573 Million USD | -27.47% |
| 2014 Q4 | 371 Million USD | -37.01% |
| 2014 Q2 | 681 Million USD | -5.55% |
| 2014 FY | 2.36 Billion USD | 14.6% |
| 2014 Q1 | 721 Million USD | 5250.0% |
| 2014 Q3 | 589 Million USD | -13.51% |
| 2013 Q1 | 765 Million USD | 200.0% |
| 2013 Q2 | 689 Million USD | -9.93% |
| 2013 Q3 | 621 Million USD | -9.87% |
| 2013 Q4 | -14 Million USD | -102.25% |
| 2013 FY | 2.06 Billion USD | 14.12% |
| 2012 Q3 | 649 Million USD | 20.63% |
| 2012 FY | 1.8 Billion USD | 0.0% |
| 2012 Q2 | 538 Million USD | 0.0% |
| 2012 Q4 | 255 Million USD | -60.71% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 3145.389% |
| Accuray Incorporated | 504 Thousand USD | -796130.159% |
| Align Technology, Inc. | 643.33 Million USD | -523.778% |
| Elevance Health Inc. | 133.96 Billion USD | 97.004% |
| AxoGen, Inc. | -21.46 Million USD | 18798.164% |
| Boston Scientific Corporation | 2.34 Billion USD | -71.276% |
| CVS Health Corporation | 13.74 Billion USD | 70.8% |
| Cardinal Health, Inc. | 1.24 Billion USD | -222.848% |
| Centene Corporation | 2.93 Billion USD | -36.962% |
| DaVita Inc. | 1.6 Billion USD | -150.377% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 58.315% |
| Hologic, Inc. | 970.2 Million USD | -313.626% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -265.773% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -453.06% |
| Masimo Corporation | 136.5 Million USD | -2839.927% |
| McKesson Corporation | 3.9 Billion USD | -2.661% |
| Patterson Companies, Inc. | 252.92 Million USD | -1486.643% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -217.987% |
| ResMed Inc. | 1.31 Billion USD | -204.04% |
| Henry Schein, Inc. | 615 Million USD | -552.52% |
| Teladoc Health, Inc. | -248.55 Million USD | 1714.545% |
| Universal Health Services, Inc. | 1.17 Billion USD | -241.421% |
| Veeva Systems Inc. | 429.33 Million USD | -834.704% |
| Baxter International Inc. | 390 Million USD | -928.974% |
| Becton, Dickinson and Company | 2.11 Billion USD | -90.099% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -127.134% |
| Danaher Corporation | 5.38 Billion USD | 25.423% |
| Stryker Corporation | 3.88 Billion USD | -3.215% |
| Medtronic plc | 5.14 Billion USD | 21.987% |